Dow's Pfizer Beats Q4 Earnings Views, Guides Higher For 2018

Georgia Reed
February 1, 2018

The Marshall Wace Llp holds 48,125 shares with $1.73M value, down from 188,820 last quarter. Pfizer a part of Healthcare sector and belongs to Drug Manufacturers - Major industry.

Shares of Pfizer fell 1.6 percent in premarket trading after initially gaining. 45,966,396 shares of the company traded hands, compared to its average volume of 22,272,664.

Pfizer (NYSE:PFE) last issued its earnings results on Tuesday, October 31st. It has underperformed by 19.46% the S&P500. The biopharmaceutical company reported $0.62 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.56 by $0.06. Golar LNG Limited had 28 analyst reports since August 18, 2015 according to SRatingsIntel. (NASDAQ:FLXN) on Wednesday, June 29 with "Outperform" rating. The stock of Trillium Therapeutics Inc. The company was maintained on Friday, November 10 by RBC Capital Markets. Wells Fargo maintained Flexion Therapeutics, Inc. As per Wednesday, October 4, the company rating was maintained by Northland Capital. The company was initiated on Thursday, October 6 by Stephens. Jefferies has "Buy" rating and $39.0 target. Cowen & Co maintained the stock with "Buy" rating in Wednesday, July 5 report. See Trillium Therapeutics Inc.

Since August 4, 2017, it had 0 insider buys, and 10 insider sales for $16.36 million activity. Also, insider Alexander R. Mackenzie sold 6,750 shares of Pfizer stock in a transaction dated Friday, December 15th.

On 12/15/2017 Rady A Johnson, EVP, sold 8,000 with an average share price of $37.07 per share and the total transaction amounting to $296,560.00. The stock of Pfizer Inc. (NYSE:PFE) was sold by OLSON LAURIE J on Monday, August 21. Shares for $1.34M were sold by SUSMAN SALLY on Tuesday, September 12.

Mourinho confirms he'll allow Ibrahimovic to leave Man Utd
The new MLS season will kicks off in March, whereas the current contract between Man United and Ibrahimović runs until June.

Innovative Health revenues increased 5 percent operationally to $8.22 billion, driven by continued growth from key brands including Eliquis, Xeljanz, Prevenar 13 as well as Lyrica, Ibrance and Chantix/Champix. The institutional investor held 142,512 shares of the health care company at the end of 2017Q3, valued at $5.09M, down from 153,111 at the end of the previous reported quarter.

Investors sentiment increased to 0.96 in Q3 2017. Its up 0.26, from 1.28 in 2017Q2. It improved, as 53 investors sold PFE shares while 700 reduced holdings.

In the heat of mergers and acquisitions of pharmaceutical and biotech companies, Pfizer finds itself in a position to expand its portfolio. (NYSE:PFE) for 11,995 shares. This is a boost from Pfizer's previous quarterly dividend of $0.32. Sii Investments Wi holds 0.2% or 97,012 shares in its portfolio. Origin Asset Management Ltd Liability Partnership holds 388,488 shares. Lincoln Natl invested in 60,433 shares or 0.09% of the stock. Chase Inv Counsel Corporation holds 0.13% or 7,175 shares in its portfolio. Sns Financial Group Llc who had been investing in Pfizer Inc for a number of months, seems to be less bullish one the $225.20B market cap company. The company forecasts quarterly dividend payments of $0.34 per share in addition to $5 billion of share repurchases. (NYSE:PFE). Navellier And Associate Incorporated holds 0.07% in Pfizer Inc. Ubs Asset Mgmt Americas has invested 0% in PICO Holdings, Inc. (NYSE:PFE) by 0.1% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. 280.42 million shares or 7.79% more from 260.14 million shares in 2017Q2 were reported. Analysts have a mean recommendation of 2.5 on this stock. Therefore 67% are positive. Piper Jaffray maintained Pfizer Inc. The company now has an average rating of "Hold" and an average target price of $38.22. The rating was downgraded by Suntrust Robinson to "Neutral" on Friday, November 13. Jefferies has "Buy" rating and $39 target. As per Thursday, April 7, the company rating was reinitiated by JP Morgan. The firm has a market cap of $232,527.17, a P/E ratio of 24.09, a PEG ratio of 2.41 and a beta of 1.01.

Investors sentiment increased to 0.7 in Q3 2017. It is positive, as 31 investors sold BERY shares while 105 reduced holdings. 116 funds opened positions while 640 raised stakes. Ledyard Bankshares has invested 0.03% of its portfolio in Sensata Technologies Holding N.V. (NYSE:ST). Meeder Asset Mgmt accumulated 2,150 shares. It also upped Clovis Oncology (NASDAQ:CLVS) stake by 12,426 shares and now owns 18,567 shares. Advent Cap Mngmt De reported 0.01% in Flexion Therapeutics, Inc. Scholtz & Limited, Connecticut-based fund reported 55,250 shares. First American Bancshares holds 0.47% or 173,180 shares in its portfolio. (NYSE:CTL). Manchester Ltd Liability Corp holds 0% or 1,234 shares in its portfolio. Goldman Sachs Gp reported 56,756 shares. State Teachers Retirement Sys invested in 0% or 11,500 shares.

Other reports by

Discuss This Article